Sustained suppression of xenoreactive natural antibodies: anti-IgM monoclonal antibody and anti-B cell immunosuppressants. 1994

W J Van der Werf, and M L Blakely, and W Hancock, and M Soares, and D Latinne, and H Bazin, and F H Bach
Sandoz Center for Immunobiology, Harvard Medical School, Boston, Massachusetts.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D010956 Plasmapheresis Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use. Double Filtration Plasmapheresis,Therapeutic Immunoadsorption,Therapeutic Plasma Adsorption,Therapeutic Plasmapheresis,Adsorption, Therapeutic Plasma,Adsorptions, Therapeutic Plasma,Double Filtration Plasmaphereses,Filtration Plasmapheresis, Double,Immunoadsorption, Therapeutic,Plasma Adsorption, Therapeutic,Plasmaphereses,Plasmapheresis, Double Filtration,Plasmapheresis, Therapeutic,Therapeutic Immunoadsorptions,Therapeutic Plasma Adsorptions,Therapeutic Plasmaphereses
D011090 Polyenes Hydrocarbons with more than one double bond. They are a reduced form of POLYYNES. Cumulenes
D011917 Rats, Inbred Lew An inbred strain of rat that is used in BIOMEDICAL RESEARCH. Rats, Inbred Lewis,Rats, Lew,Inbred Lew Rat,Inbred Lew Rats,Inbred Lewis Rats,Lew Rat,Lew Rat, Inbred,Lew Rats,Lew Rats, Inbred,Lewis Rats, Inbred,Rat, Inbred Lew,Rat, Lew
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

W J Van der Werf, and M L Blakely, and W Hancock, and M Soares, and D Latinne, and H Bazin, and F H Bach
October 1994, Immunological reviews,
W J Van der Werf, and M L Blakely, and W Hancock, and M Soares, and D Latinne, and H Bazin, and F H Bach
December 1993, Transplantation,
W J Van der Werf, and M L Blakely, and W Hancock, and M Soares, and D Latinne, and H Bazin, and F H Bach
August 1998, Transplantation,
W J Van der Werf, and M L Blakely, and W Hancock, and M Soares, and D Latinne, and H Bazin, and F H Bach
December 1999, Transplantation,
W J Van der Werf, and M L Blakely, and W Hancock, and M Soares, and D Latinne, and H Bazin, and F H Bach
June 1994, Transplantation proceedings,
W J Van der Werf, and M L Blakely, and W Hancock, and M Soares, and D Latinne, and H Bazin, and F H Bach
July 1981, Cellular immunology,
W J Van der Werf, and M L Blakely, and W Hancock, and M Soares, and D Latinne, and H Bazin, and F H Bach
December 1999, Cellular and molecular life sciences : CMLS,
W J Van der Werf, and M L Blakely, and W Hancock, and M Soares, and D Latinne, and H Bazin, and F H Bach
January 1985, Experimental cell biology,
W J Van der Werf, and M L Blakely, and W Hancock, and M Soares, and D Latinne, and H Bazin, and F H Bach
October 1991, Transplantation,
W J Van der Werf, and M L Blakely, and W Hancock, and M Soares, and D Latinne, and H Bazin, and F H Bach
April 1996, Transplantation proceedings,
Copied contents to your clipboard!